EUVIMEDEUVIMED entdecken
Open Access

Endogenous Glucagon‐Like Peptide‐1 Receptor and Glucose‐Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen‐Induced Innate Airway Inflammation

Shinji Toki iD, Masako Abney, Jian Zhang, Mark Rusznak, Christian M Warren, Dawn C Newcomb iD, Katherine N Cahill, Daniel J Drucker, Kevin D Niswender, Ray Stokes Peebles

Allergy · 2024

DOI: 10.1111/all.16402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Shinji Toki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Allergens, Signal Transduction, Mice, Knockout, Immunity, Innate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti‐inflammatory effects of incretin signaling through the glucagon‐like peptide‐1 receptor (GLP‐1R) and the glucose‐dependent insulinotropic polypeptide receptor (GIPR) in mice have been reported. Therefore, we hypothesized that signaling through the endogenous GLP‐1R and the GIPR individually decreases allergic airway inflammation and that the combination of GLP‐1R and GIPR signaling together additively inhibits allergen‐induced lung and airway inflammation.

Methods

WT (C57BL/6J), GLP‐1R knockout (KO), GIPR KO, and GLP‐1R/GIPR double KO (DKO) mice were challenged intranasally with Alternaria alternata extract (Alt‐Ext) or vehicle to evaluate the impact of signaling through these receptors on the innate allergen‐induced inflammatory response that is primarily driven by group 2 innate lymphoid cells (ILC2).

Results

Alt‐Ext‐induced IL‐33 release in the bronchoalveolar lavage fluid (BALF) was not different between the mouse strains, but thymic stromal lymphopoietin (TSLP) was significantly increased in GLP‐1R/GIPR DKO mice challenged with Alt‐Ext compared to the other strains. Furthermore, Alt‐Ext‐induced protein expression of IL‐5, IL‐13, CCL11, and CCL24 in the lung homogenates, the number of eosinophils, lymphocytes, and neutrophils in the BALF, and the number of lung GATA3+ ILC2 were significantly increased in GLP‐1R/GIPR DKO mice compared to the other 3 strains. Furthermore, ICAM‐1 expression on lung epithelial cells was increased in GLP‐1R/GIPR DKO mice challenged with Alt‐Ext compared to the other 3 strains.

Conclusions

Deficiency of both GLP‐1R and GIPR signaling together increased TSLP release, ILC2 activation, and early type 2 innate immune responses to aeroallergen exposure. Combined GLP‐1R and GIPR signaling should be explored for the treatment of asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensSignal TransductionMice, KnockoutImmunity, InnateGlucagon-Like Peptide-1 ReceptorReceptors, Gastrointestinal HormoneAnimalsMiceAlternariaCytokinesDisease Models, AnimalBronchoalveolar Lavage FluidMice, Inbred C57BLLung

Stichwörter der Autor:innen

GIPRGLP‐1Rallergyasthmaincretin

Substanzen

AllergensGlucagon-Like Peptide-1 Receptorgastric inhibitory polypeptide receptorReceptors, Gastrointestinal HormoneCytokines

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • United States Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
  • Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

ORCID-Profile: Shinji Toki, Dawn C Newcomb

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • BLRD VA
  • U.S. Department of Veterans Affairs
  • CIHR
  • National Institutes of Health
  • Canadian Institutes of Health Research

Zitieren

APA

Toki, S., Abney, M., Zhang, J., Rusznak, M., Warren, C. M., Newcomb, D. C., Cahill, K. N., Drucker, D. J., Niswender, K. D., & Peebles, R. S. (2024). Endogenous Glucagon‐Like Peptide‐1 Receptor and Glucose‐Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen‐Induced Innate Airway Inflammation. Allergy. https://doi.org/10.1111/all.16402

Vancouver

Toki S, Abney M, Zhang J, Rusznak M, Warren CM, Newcomb DC, et al. Endogenous Glucagon‐Like Peptide‐1 Receptor and Glucose‐Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen‐Induced Innate Airway Inflammation. Allergy. 2024. doi:10.1111/all.16402

BibTeX
@article{Toki2024,
  author = {Toki, Shinji and Abney, Masako and Zhang, Jian and Rusznak, Mark and Warren, Christian M and Newcomb, Dawn C and Cahill, Katherine N and Drucker, Daniel J and Niswender, Kevin D and Peebles, Ray Stokes},
  title = {Endogenous Glucagon‐Like Peptide‐1 Receptor and Glucose‐Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen‐Induced Innate Airway Inflammation},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16402}
}
Kostenlos starten →